Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

How to Place Diagonal Debit Spreads if You’re Slightly Bullish: https://www.marketbeat.com/logos/articles/med_20240703064811_nvda--stock.jpg
How to Place Diagonal Debit Spreads if You’re Slightly Bullish

Using stock options can help manage risk, providing you with different ways to trade an underlying stock in the direction you believe it will go. Most of the options spread strategies we’ve

AI Boom: Micron Stock Dip vs. NVIDIA's Upgrade – Which Is Better?: https://www.marketbeat.com/logos/articles/med_20240708144053_ai-boom-micron-stock-dip-vs.jpg
AI Boom: Micron Stock Dip vs. NVIDIA's Upgrade – Which Is Better?

Most of the market’s attention has floated to the technology sector today, focused on the companies most exposed to developments around artificial intelligence and its expanding adoption in the

UiPath’s GenAI Expansion Could Skyrocket Its Value - Rally Ahead?: https://www.marketbeat.com/logos/articles/med_20240707185225_chartht-path.jpg
UiPath’s GenAI Expansion Could Skyrocket Its Value - Rally Ahead?

UiPath Inc. (NYSE: PATH) is the leader in robotic process automation (RPA) and business process automation (BPA). The company has been involved with artificial intelligence (AI) for years, using

Hot Stock Splits Ahead: 3 Major Ones to Put on Your Watchlist: https://www.marketbeat.com/logos/articles/med_20240708103048_chart-ctas-782024ver001.png
NVIDIA Stock Defies Skeptics, Earns Analyst Upgrade: https://www.marketbeat.com/logos/articles/med_20240708103548_nvidia-stock-defies-skeptics-earns-analyst-upgrade.jpg
NVIDIA Stock Defies Skeptics, Earns Analyst Upgrade

NVIDIA Corporation (NASDAQ: NVDA) is one of the dominant forces in the artificial intelligence (AI) sector. The company continues to be a hot topic among investors and the semiconductor analyst

3 Highly Profitable Companies Set for Double-Digit Upside: https://www.marketbeat.com/logos/articles/med_20240708101350_3-highly-profitable-companies-set-for-double-digit.jpg
3 Highly Profitable Companies Set for Double-Digit Upside

Most investors fail to realize that a stock price has nothing to do with the underlying company, as more than 90% of the time, there is a wide gap between value and price. How come businesses like

Arm Holdings Stock Soars: Powering the Edge AI Revolution with v9: https://www.marketbeat.com/logos/articles/med_20240707184622_charth-arm.jpg
Arm Holdings Stock Soars: Powering the Edge AI Revolution with v9

U.K.-based semiconductor company Arm Holdings plc (NASDAQ: ARM) stock is up 141% year-to-date (YTD). The artificial intelligence (AI) revolution is driving big gains as it becomes more apparent

MGM Resorts Stock: Poised for Hospitality Industry Rebound: https://www.marketbeat.com/logos/articles/med_20240707182807_charth-mgm.jpg
MGM Resorts Stock: Poised for Hospitality Industry Rebound

Casino stocks are the proverbial “rough neighborhood” in 2024, with the major players like Las Vegas Sands Co. (NYSE: LVS) and Wynn Resorts Ltd. (NASDAQ: WYNN) trading down 14.4% and 9.22%

What Makes These 7 Stocks Magnificent?: https://www.marketbeat.com/logos/articles/med_20240705142314_what-makes-these-7-stocks-magnificent.jpg
What Makes These 7 Stocks Magnificent?

Coined by Bank of America’s chief investment strategist Michael Hartnett, the Magnificent 7 is a group of seven technology companies known for their significant market capitalization and impact on

Baidu Stock Nears Pandemic Lows: Is This a Buying Opportunity?: https://www.marketbeat.com/logos/articles/med_20240707184146_charthbidu.jpg
Baidu Stock Nears Pandemic Lows: Is This a Buying Opportunity?

Chinese technology stocks have been taking a tumble in 2024. A combination of geopolitical and trade tensions, macroeconomic uncertainty, and growth slowdown have been negative drivers that have

Qualcomm Stock Continues to Rise in the Face of Negative News: https://www.marketbeat.com/logos/articles/med_20240705092924_qualcomm-stock-continues-to-rise-in-the-face-of-ne.jpg
Qualcomm Stock Continues to Rise in the Face of Negative News

Qualcomm (NASDAQ: QCOM) is one of the leading players in the semiconductor industry. The firm has outperformed the market and industry over the past 12 months, with a total return of 75%. Over the

Forget NVIDIA: Super Micro Computer Stock Leads in Momentum: https://www.marketbeat.com/logos/articles/med_20240703105608_forget-nvidia-super-micro-computer-stock-leads-in.jpg
Forget NVIDIA: Super Micro Computer Stock Leads in Momentum

That's right, the better stock to watch for those investors who value momentum over everything else in the technology sector is not actually NVIDIA Co. (NASDAQ: NVDA). Understanding that the

CrowdStrike Stock Soars, Outpacing Palo Alto in Cybersecurity: https://www.marketbeat.com/logos/articles/med_20240702131427_crowdstrikes-stock-outlook-vs.jpg
CrowdStrike Stock Soars, Outpacing Palo Alto in Cybersecurity

CrowdStrike Holdings (NASDAQ: CRWD) is a technology firm specializing in  AI-powered cybersecurity. It has recently seen massive share price growth, up 162% in the last 12 months. Since going

3 Cybersecurity Stocks to Watch: CrowdStrike, Zscaler, Fortinet: https://www.marketbeat.com/logos/articles/med_20240702112533_3-cybersecurity-stocks-to-watch-crowdstrike-zscale.jpg
3 Cybersecurity Stocks to Watch: CrowdStrike, Zscaler, Fortinet

The technology sector continues to drive the overall market higher, with cybersecurity stocks presenting intriguing setups. Software infrastructure and cybersecurity stocks have performed modestly

Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex: https://www.marketbeat.com/logos/articles/med_20240702093329_biotech-stock-breakout-ibb-eyes-major-resistance-l.jpg
Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex

The biotechnology sector, represented by the iShares Biotechnology ETF (NASDAQ: IBB), has experienced a year of consolidation. With the ETF up just 0.8%, it has underperformed the broader market

The Top 4 Magnificent 7 Stocks to Buy in the Year's Second Half: https://www.marketbeat.com/logos/articles/med_20240701140119_the-top-4-magnificent-7-stocks-to-buy-in-the-years.jpg
The Top 4 Magnificent 7 Stocks to Buy in the Year's Second Half

As investors prepare for the second half of the year, one question is whether they should take NVIDIA Corp. (NASDAQ: NVDA) or the field. In this case, the field refers to other stocks that make up

Complete Solaria, Senti, and POET: 3 High Volume Penny Stocks: https://www.marketbeat.com/logos/articles/med_20240701124548_chart-poet-712024ver001.png
Complete Solaria, Senti, and POET: 3 High Volume Penny Stocks

High volume can indicate market strength, but volume is relative. Thirty million in traded shares doesn’t mean much if the average daily volume is higher. However, a volume spike to thirty million

The 2 Most Downgraded Stocks: Sell One, Buy the Other: https://www.marketbeat.com/logos/articles/med_20240701155321_chart-wday-712024ver001.png
The 2 Most Downgraded Stocks: Sell One, Buy the Other

Analysts' sentiment has Workday (NASDAQ: WDAY)  and SolarEdge (NASDAQ: SEDG) down, but the takeaways differ for each. On the one hand, a struggling business continues to lose money while its

Fortinet: An Undervalued Cybersecurity Stock Worth Owning: https://www.marketbeat.com/logos/articles/med_20240630173353_charty-ftnt.jpg
Fortinet: An Undervalued Cybersecurity Stock Worth Owning

Leading cybersecurity provider Fortinet Inc. (NASDAQ: FTNT) stock has been lagging behind its peers and the benchmark indexes, trading up just 3.8% year-to-date (YTD). The company offers

3 Recent Stock Buybacks: Adobe, Marathon, and FedEx Lead the Way: https://www.marketbeat.com/logos/articles/med_20240701072843_3-recent-stock-buybacks-adobe-marathon-and-fedex-l.jpg
3 Recent Stock Buybacks: Adobe, Marathon, and FedEx Lead the Way

When investors consider the main ways to get their money back from an investment and a reasonable return on that initial investment, the average retail investor thinks of two main approaches

Affirm Holdings Stock: Is It Time to Buy Now and Get Paid Later?: https://www.marketbeat.com/logos/articles/med_20240630173807_charty-afrm.jpg
Affirm Holdings Stock: Is It Time to Buy Now and Get Paid Later?

Affirm Holdings Inc. (NASDAQ: AFRM) is a leader in the buy-now-pay-later (BNPL) industry. They provide installment loans to consumers, enabling them to split purchases into smaller payments

Qualcomm Stock: AI-Powered Growth Despite Volatility: https://www.marketbeat.com/logos/articles/med_20240628114804_qualcomm-stock-ai-powered-growth-despite-volatilit.jpg
Qualcomm Stock: AI-Powered Growth Despite Volatility

Qualcomm (NASDAQ: QCOM) is a dominant force in the semiconductor industry, designing and manufacturing wireless communication products and solutions. The industry is undergoing a significant

Tesla Stock's Comeback Rally Has Officially Started: https://www.marketbeat.com/logos/articles/med_20240628082511_tesla-stocks-comeback-rally-has-officially-started.jpg
Tesla Stock's Comeback Rally Has Officially Started

It's been a funny year for investors and shares of Tesla Inc. (NASDAQ: TSLA). This year, it has broken its long track record of delivering outperformance even when the broader market is

EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R): https://mms.businesswire.com/media/20210106005629/en/850492/5/KO_LOGO_%28002%29.jpg
EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R)

Moderna, Inc. (Nasdaq:MRNA) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the

Ausschuss für Humanarzneimittel der EMA gibt positive Stellungnahme ab und empfiehlt Marktzulassung von Modernas RSV-Impfstoff mRESVIA(R): https://mms.businesswire.com/media/20210106005629/en/850492/5/KO_LOGO_%28002%29.jpg
Ausschuss für Humanarzneimittel der EMA gibt positive Stellungnahme ab und empfiehlt Marktzulassung von Modernas RSV-Impfstoff mRESVIA(R)

CAMBRIDGE, MA / ACCESSWIRE / 28. Juni 2024 / Moderna, Inc. (Nasdaq: MRNA) hat heute bekannt gegeben, dass der Ausschuss für Humanarzneimittel (CHMP) der Europäischen Arzneimittel-Agentur